Y-Intercept (HK)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,878
Closed -$1.34M – 2021
2026
Q2
$1.34M Sell
6,878
-13,373
-66% -$2.77M 0.03% 908
2026
Q1
$4.55M Buy
20,251
+6,426
+46% +$1.6M 0.09% 353
2025
Q4
$3.33M Buy
13,825
+5,105
+59% +$1.31M 0.07% 378
2025
Q3
$2.39M Buy
+8,720
New +$2.38M 0.06% 509
2024
Q4
– Sell
-843
Closed -$206K – 1585
2024
Q3
$206K Sell
843
-6,375
-88% -$1.42M 0.01% 1157
2024
Q2
$1.38M Buy
+7,218
New +$1.46M 0.08% 364
2024
Q1
– Sell
-5,466
Closed -$940K – 1698
2023
Q4
$940K Buy
+5,466
New +$840K 0.09% 341
2023
Q2
– Sell
-3,725
Closed -$816K – 1656
2023
Q1
$816K Sell
3,725
-1,802
-33% -$391K 0.09% 316
2022
Q4
$1.15M Buy
+5,527
New +$1.21M 0.17% 166
2022
Q1
– Sell
-1,292
Closed -$337K – 916
2021
Q4
$337K Sell
1,292
-5,547
-81% -$1.44M 0.08% 363
2021
Q3
$1.8M Buy
+6,839
New +$1.87M 0.33% 79
2021
Q1
– Sell
-1,136
Closed -$238K – 771
2020
Q4
$238K Buy
+1,136
New +$227K 0.1% 394

Other funds holding RMD

Y-Intercept (HK)'s RMD Position: Q3 2026 in Review

Y-Intercept (HK) sold out of ResMed (RMD) in Q3 2026, closing a stake of 6,878 shares — an estimated $1.34M sold.

Y-Intercept (HK) first reported a position in RMD in Q4 2020 and held it in 12 quarters. The position peaked at $4.55M in Q1 2026. 442 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Y-Intercept (HK) reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 6,878 ResMed shares in Q3 2026, an estimated $1.34M.
  • Y-Intercept (HK) first reported a position in ResMed in Q4 2020 and held it in 12 quarters.
  • Y-Intercept (HK)'s ResMed position peaked at $4.55M in Q1 2026.
  • 442 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.